Abstract: 7-Azabicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.
Type:
Grant
Filed:
August 20, 1996
Date of Patent:
May 9, 2000
Assignee:
UCB S.A. - DTB
Inventors:
T. Y. Shen, W. Dean Harman, Dao Fei Huang, Javier Gonzalez